Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:722

Biotron Limited (BIT) - Financial and Strategic SWOT Analysis Review

Biotron Limited (BIT) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Biotron Limited (Biotron) is a biotechnology company. The company undertakes the development and commercialization of novel therapeutics and diagnostics that address a range of significant health issues. Its intermediate and applied technologies and resea
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Biotron Limited (Biotron) is a biotechnology company. The company undertakes the development and commercialization of novel therapeutics and diagnostics that address a range of significant health issues. Its intermediate and applied technologies and research and development programs are used in treatment of hepatitis C virus (HCV), human immunodeficiency virus (HIV), Dengue virus and Influenza virus. Its offers a wide portfolio of clinical and preclinical antiviral programs that include drugs targeting viral proteins, namely, p7, Vpu, and M protein. The company's flagship product, BIT225 is under development stage and has completed Phase 2a clinical trial in HCV.

This comprehensive SWOT profile of Biotron Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Biotron Limited - Key Facts 4
Biotron Limited - Key Employees 5
Biotron Limited - Key Employee Biographies 6
Biotron Limited - Major Products and Services 7
Biotron Limited - Pharmaceutical Pipeline Products Data 8
Biotron Limited, Pipeline Products by Therapy Area 8
Biotron Limited, Pipeline Products by Development Phase 9
Biotron Limited - History 11
Biotron Limited - Company Statement 13
Biotron Limited - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Biotron Limited - Business Description 15
Biotron Limited - Corporate Strategy 16
Biotron Limited - SWOT Analysis 17
SWOT Analysis - Overview 17
Biotron Limited - Strengths 17
Strength - Robust Research and Development Platform 17
Strength - Robust Patent Portfolio 17
Strength - Improved Liquidity Position 17
Biotron Limited - Weaknesses 17
Weakness - Dependence on Government Grants 17
Weakness - History of Losses 18
Biotron Limited - Opportunities 18
Opportunity - Agreements and Collaborations 18
Opportunity - Focus on Major Therapeutic Areas 18
Opportunity - Emerging Markets 18
Biotron Limited - Threats 18
Threat - Tough Credit Market Conditions 18
Threat - Uncertainties in R&D 19
Threat - Technological Obsolescence 19
Biotron Limited - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Biotron Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 26
Biotron Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 27
Biotron Limited, Recent Deals Summary 28
Section 5 – Appendix 29
Methodology 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Biotron Limited, Key Facts 4
Biotron Limited, Key Employees 5
Biotron Limited, Key Employee Biographies 6
Biotron Limited, Major Products and Services 7
Biotron Limited, Number of Pipeline Products by Therapy Area 8
Biotron Limited, Number of Pipeline Products by Development Stage 9
Biotron Limited, Pipeline Products By Therapy Area and Development Phase 10
Biotron Limited, History 11
Biotron Limited, Other Locations 14
Biotron Limited, Key Competitors 20
Biotron Limited, Ratios based on current share price 21
Biotron Limited, Annual Ratios 21
Biotron Limited, Interim Ratios 24
Biotron Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 26
Biotron Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 27
Biotron Limited, Recent Deals Summary 28
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32

List of Figures
Biotron Limited, Pipeline Products by Therapy Area 8
Biotron Limited, Pipeline Products by Development Phase 9
Biotron Limited, Performance Chart (2008 - 2012) 23
Biotron Limited, Ratio Charts 25
Biotron Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 26
Biotron Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 27




...